IP Library Granted Patent US 10,821,077
Granted Patent B2
US 10,821,077 · App. 15/903,275 · Granted Nov 3, 2020

Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof

Inventors: Dov Tamarkin (Maccabim, IL); Doron Friedman (Karmei Yosef, IL); Tal Berman (Rishon le Ziyyon, IL); Enbal Ziv (Gedera, IL); David Schuz (Gimzu, IL)
Assignee: Foamix Pharmaceuticals Ltd.
A61K9/122A01N25/16A61K8/046A61K8/362A61K8/37A61K8/4993A61K8/86A61K9/0014A61Q19/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,821,077
App. No.
15/903,275
Granted
Nov 3, 2020
Kind
B2
Abstract

The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients. The invention further relates to a foamable composition further containing a liquefied hydrocarbon gas propellant.

Claims (11)

1. A foamable composition comprising a carrier and a liquefied or a compressed gas propellant, the carrier comprising:

i. a dicarboxylic acid ester;

ii. about 0.1% to about 5% by weight of the carrier of at least one surface-active agent;

iii. about 2% to about 50% by weight of the carrier of at least one hydrophobic solvent; and

iv. water,

wherein the composition does not comprise a polymeric gelling agent; and

wherein upon release from a foam dispenser, a foam is produced.

2. The foamable composition of claim 1 , wherein the carrier is an emulsion.

3. The foamable composition of claim 1 , wherein the at least one surface-active agent has a hydrophilic/lipophilic balance (HLB) value of between about 9 and about 14.

4. The foamable composition of claim 1 , further comprising a retinoid.

5. The foamable composition of claim 4 , wherein the dicarboxylic acid ester is diisopropyl adipate and the at least one hydrophobic solvent is mineral oil.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE PHARMACEUTICALS LTD. (F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0138 →
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0708 →
PATENT SECURITY AGREEMENT Recorded Feb 17, 2021
From: VYNE THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 055326/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: VYNE PHARMACEUTICALS LTD.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055215/0298 →
CHANGE OF NAME Recorded Nov 4, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: VYNE PHARMACEUTICALS LTD.
Reel/Frame 054306/0387 →
CHANGE OF NAME Recorded Aug 28, 2020
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS LTD.
Reel/Frame 053635/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2020
From: TAMARKIN, DOV; FRIEDMAN, DORON; BERMAN, TAL; ZIV, ENBAL; SCHUZ, DAVID
To: FOAMIX LTD.
Reel/Frame 053627/0619 →
PATENT SECURITY AGREEMENT Recorded Jul 30, 2019
From: FOAMIX PHARMACEUTICALS LTD
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 049912/0045 →
Priority Claims (1)
IL 152486 · Oct 25, 2002 · national
Continuity (15)
Continuation 13796860 · Mar 12, 2013
Continuation 11825406 · Jul 5, 2007
Continuation In Part 10532618
Continuation In Part 10911367 · Aug 4, 2004
Continuation In Part 11653205 · Jan 12, 2007
Continuation In Part 10835505 · Apr 28, 2004
Continuation In Part 10911367 · Aug 4, 2004
Continuation In Part 11717897 · Mar 13, 2007
Continuation In Part 11078902 · Mar 11, 2005
Provisional Application 60818634 · Jul 5, 2006
Provisional Application 60429546 · Nov 29, 2002
Provisional Application 60492385 · Aug 4, 2003
Provisional Application 60530015 · Dec 16, 2003
Related Publication 20190022001A1 · Jan 24, 2019
Related Publication 20190247310A9 · Aug 15, 2019
Cited By (1)
US 12,661,407